Regeneron Reports Q3 EPS of $20.07, $3.65 Above Expectations
Regeneron reported Q3 earnings of $20.07 per share, excluding non-recurring items, $3.65 better than expectations. Revenue also beat, according to the headline.
Story updates
10:56:58 AM UTC
SquawkNews
WASHINGTON (dpa-AFX) - Regeneron Pharmaceuticals Inc (REGN) reported earnings for its third quarter that Increases, from last yearThe company's earnings totaled $1.949 billion, or $18.45 per share. This compares with $1.460 billion, or $13.62 per share, last year.Excluding items, Regeneron Pharmac…